Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Specific prescription medications as drivers of out-of-pocket payments and cost-related medication non-adherence in the Czech Republic

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43110%2F21%3A43919825" target="_blank" >RIV/62156489:43110/21:43919825 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://doi.org/10.32725/kont.2021.020" target="_blank" >https://doi.org/10.32725/kont.2021.020</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.32725/kont.2021.020" target="_blank" >10.32725/kont.2021.020</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Specific prescription medications as drivers of out-of-pocket payments and cost-related medication non-adherence in the Czech Republic

  • Popis výsledku v původním jazyce

    Objective: Out-of-pocket payments for medications take a substantial part of Czech households&apos; expenditure for health, which could have a negative impact on medication adherence. Therefore, the objective of this study is to explore the impact of prescription medications related to specific health conditions on patients&apos; out-of-pocket payments and cost-related medication non-adherence. Methods: We used the data from the second wave of the European Health Interview Survey. Running the analyses in hierarchical stages, our main interest was the influence of medications related to 21 health conditions. A conventional regression method with robust standard errors was used for the investigation of out-of-pocket payments for prescription medication. Predictors of cost-related medication nonadherence were identified using a logistic regression model. Results: We found that medications for stroke, asthma, myocardial infarction, chronic lung disease, chronic kidney disease, and diabetes contribute to high co-payments. Moreover, cost sharing for stroke, asthma and myocardial infarction medications might have serious implications for desirable consumption as they are associated with medication non-adherence. Conclusions: We conclude that prescription practices and reimbursement policies in relation to medications for stroke, asthma and myocardial infarction should be carefully explored and physicians should be motivated to prescribe medications covered fully or with low co-payments.

  • Název v anglickém jazyce

    Specific prescription medications as drivers of out-of-pocket payments and cost-related medication non-adherence in the Czech Republic

  • Popis výsledku anglicky

    Objective: Out-of-pocket payments for medications take a substantial part of Czech households&apos; expenditure for health, which could have a negative impact on medication adherence. Therefore, the objective of this study is to explore the impact of prescription medications related to specific health conditions on patients&apos; out-of-pocket payments and cost-related medication non-adherence. Methods: We used the data from the second wave of the European Health Interview Survey. Running the analyses in hierarchical stages, our main interest was the influence of medications related to 21 health conditions. A conventional regression method with robust standard errors was used for the investigation of out-of-pocket payments for prescription medication. Predictors of cost-related medication nonadherence were identified using a logistic regression model. Results: We found that medications for stroke, asthma, myocardial infarction, chronic lung disease, chronic kidney disease, and diabetes contribute to high co-payments. Moreover, cost sharing for stroke, asthma and myocardial infarction medications might have serious implications for desirable consumption as they are associated with medication non-adherence. Conclusions: We conclude that prescription practices and reimbursement policies in relation to medications for stroke, asthma and myocardial infarction should be carefully explored and physicians should be motivated to prescribe medications covered fully or with low co-payments.

Klasifikace

  • Druh

    J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS

  • CEP obor

  • OECD FORD obor

    50902 - Social sciences, interdisciplinary

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2021

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Kontakt

  • ISSN

    1212-4117

  • e-ISSN

    1804-7122

  • Svazek periodika

    23

  • Číslo periodika v rámci svazku

    2

  • Stát vydavatele periodika

    NL - Nizozemsko

  • Počet stran výsledku

    6

  • Strana od-do

    120-125

  • Kód UT WoS článku

    000848893500010

  • EID výsledku v databázi Scopus

    2-s2.0-85106485397